title: Re: luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength.
authors.forename: Samuele
authors.initials: S
authors.lastname: Marcora
authors.forename: Samuel
authors.initials: S
authors.lastname: Oliver
authors.forename: Nichola
authors.initials: N
authors.lastname: Callow
authors.forename: Andrew
authors.initials: A
authors.lastname: Lemmey
authors.forename: Nick
authors.initials: N
authors.lastname: Stuart
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000726:Androgen Antagonists / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005080:Exercise Test; D005500:Follow-Up Studies; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D018485:Muscle Fibers, Skeletal / Q000187:drug effects; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000502:physiology; D009367:Neoplasm Staging; D010809:Physical Fitness / Q000502:physiology*; D010865:Pilot Projects; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D012016:Reference Values; D016896:Treatment Outcome
chemical_list: D000726:Androgen Antagonists; D007987:Gonadotropin-Releasing Hormone